Managing GLP-1 Side Effects
What to expect when starting GLP-1 medication, how to manage common side effects, and when to contact your physician.
Last clinically reviewed: May 13, 2026 by the Imbue Health Medical Team
Common Side Effects
GLP-1 medications work by slowing gastric emptying and signaling fullness to the brain. This mechanism, while highly effective for weight loss, commonly produces gastrointestinal side effects — especially during the initial weeks and during dose increases.
Most Common Side Effects (Mild to Moderate)
Nausea (20–44% of patients)
Most common; usually improves within 4–8 weeks
Diarrhea (15–30%)
Typically mild and self-resolving
Vomiting (5–24%)
More common during dose titration
Constipation (10–24%)
Hydration and fiber can help
Abdominal pain (5–20%)
Usually mild cramping
Headache (10–15%)
Typically resolves within first few weeks
Fatigue (5–10%)
Often related to reduced caloric intake
Injection site reactions (5–10%)
Injectable only; mild redness or itching
How Imbue Physicians Manage Side Effects
Side effect management is a core part of your Imbue Health care. Your physician uses standardized titration protocols — starting at the lowest dose and increasing gradually over weeks — to minimize GI symptoms. This approach gives your body time to adjust.
Our Approach
- Gradual dose titration following manufacturer guidelines
- Proactive check-ins at every dosage change
- Dietary guidance to reduce nausea (smaller meals, avoiding high-fat foods)
- Dosage adjustment if side effects persist beyond the expected window
- Medication switching if one GLP-1 isn't well-tolerated
- Direct messaging with your physician — no appointment needed
Serious Side Effects (Rare)
While rare, GLP-1 medications carry important safety warnings. All FDA-approved GLP-1 medications include a boxed warning about thyroid C-cell tumors observed in animal studies. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Other rare but serious risks include pancreatitis, gallbladder disease, and kidney problems. Your Imbue Health physician screens for these contraindications during your initial evaluation and monitors for warning signs throughout treatment. For complete safety information, visit our Safety Information page.
What Happens When You Stop?
Clinical studies consistently show that most patients regain a significant portion of lost weight within 12 months of stopping GLP-1 medication. The STEP 1 extension trial found that patients regained approximately two-thirds of their weight loss after discontinuation.
This is why obesity medicine specialists increasingly view GLP-1 treatment as a long-term therapy — similar to medications for hypertension or diabetes. The underlying biology that caused weight gain doesn't change when you stop the medication. Your Imbue Health physician will discuss a sustainable plan whether you continue treatment, adjust to a lower maintenance dose, or taper off.
Expert-managed care from day one
Your Imbue Health physician manages your titration, monitors side effects, and adjusts your treatment — all included in your $29/mo membership.
Start Free Consultation$29/mo membership. Cancel anytime. No contracts.